SLATE RUN PHARMA
GenericsSLATE RUN PHARMA is a generic drug manufacturer focused on Infectious Disease, Cardiovascular, Respiratory.
SLATE RUN PHARMA's Key Drugs
SLATE RUN PHARMA's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).
SLATE RUN PHARMA's Recent FDA Approvals
New NDA/BLA approvals for SLATE RUN PHARMA over the last two years — novel drugs only, excluding generics and label supplements.
SLATE RUN PHARMA's Therapeutic Areas
SLATE RUN PHARMA's approved drugs and pipeline span 5 therapeutic areas, led by Infectious Disease and Cardiovascular. Weighted by commercial stage — approved drugs count most, then late-stage trials.
SLATE RUN PHARMA's Top Competitors
SLATE RUN PHARMA's closest competitors by therapeutic-area and drug-target overlap include APOTHECON, Merck, and Baxter. Ranked by overlap in therapeutic areas and drug targets across approved drugs and pipeline.
SLATE RUN PHARMA Pipeline Snapshot
Active clinical trials for SLATE RUN PHARMA across all therapeutic areas, from ClinicalTrials.gov.
Pro Intelligence Preview
Deep insights for investors and analysts
Revenue Insights
- • Top drug revenue breakdown
- • Drug-level revenue analysis
Trial Catalysts
- • Infectious Disease pipeline focus
- • Phase 3 readout tracking
Patent Risk
- • Patent expiration timeline
- • Revenue at risk analysis
Compare Companies
- • Side-by-side pipeline analysis
- • Revenue & market share comparison
Revenue forecasts • Trial milestones • Patent risk modeling
Active (0)
Discontinued (0)
Company Info
- First Approval
- 2006-03-29
- Latest
- 2025-03-31
- Applications
- 19